BCDA vs VTR · $14.4M cap vs P/E 149, rev $4.92B
Biocardia Inc (BCDA) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
BCDA does not have a complete income-statement cache yet.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
BCDA currently screens at market cap $14.4M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the BCDA and VTR stock pages for the full models.
Not investment advice.